BioArctic AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
For the nine months, sales was SEK 604.97 million compared to SEK 226.2 million a year ago. Revenue was SEK 608.61 million compared to SEK 227.52 million a year ago. Net income was SEK 316.49 million compared to SEK 46.7 million a year ago. Basic earnings per share from continuing operations was SEK 3.59 compared to SEK 0.53 a year ago. Diluted earnings per share from continuing operations was SEK 3.58 compared to SEK 0.53 a year ago.